With the help of AI, blockchain, and a new cryptocurrency, Nebula wants to give patients more control of their genomic data.
George Church's Nebula is teaming with Hong Kong startup Longenesis to create a secure platform for individuals and biobanks to sell access to their genomes.
Luna DNA, which offers a cryptocurrency to reward people for sharing biological and medical data with researchers, has raised $4 million to date.
Startup Seqster will offer its personal health records platform for donors to manage EHR, wearables, and genomic information through the blood bank's web portal.
The company said that recent regulatory and reimbursement decisions have been favorable and will help spur adoption of clinical NGS testing.
Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.
In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.
The company is hoping that consumers will use its platform to manage their health data, to participate in research, and to learn about their own and their family's health risks.
Researchers will study the genetic underpinnings of cancer, heart disease, and respiratory illness by delving into the exome sequencing data from 40,000 Northern Nevadans.
The 4,000-participant study will use a digital enrollment platform and will provide free genetic testing as well as support from doctors and genetics experts.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.